FDA.reportPublic FDA data

Zepbound 12.5 MG/ML Injectable Solution

RxCUI
2732440
RxNorm name
Zepbound 12.5 MG/ML Injectable Solution
Display name
Zepbound 12.5 MG/ML Injectable Solution
Full name
Zepbound 12.5 MG/ML Injectable Solution
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZepboundTIRZEPATIDEEli Lilly and Company487cd7e7-434c-4925-99fa-aa80b1cc776b2026-04-22Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2732440

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
487cd7e7-434c-4925-99fa-aa80b1cc776bzepbound 12.5 MG/ML Injectable Solution [PSN] · tirzepatide 12.5 MG/ML Injectable Solution [Zepbound] [SBD] · Zepbound 12.5 MG/ML Injectable Solution [SY]338These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422